Cephalosporin Classification
Cephalosporins may be classified by
their antimicrobial spectrum into four
generations
or
Some divide cephalosporins in seven
groups
ACTA FAC. MED. NAISS. 2003; 20 (2): 131-136
Cephalosporin Classification
Generation Oral Parenteral
I cephalexin cefamezin
II cefaclor cefamandole
III ceftibuten
cefpodoxime
cefixime
cefotaxime
cefoperazone
ceftriaxone
ceftazidime
IV cefepime
cefpirome
Cephalosporin Classification
Group 1
(I-P)
Group 2
(I-O)
Group 3
(II-P)
Group 4
(III-P)
Cephaloridine
Cephalothin
Cephapirin
Cefazolin
Ceforanide
Cefadroxil
Cefaclor
Cephalexin
Cephradine
Loracarbef
Cefamandole
Cefoxitin
Cefonicid
Cefotetan
Cefuroxime
Cefotaxime
Ceftizoxime
Ceftriaxone
Cephalosporin Classification
Group 5
(III-O)
Group 6
(III-P)
Group 7
(IV-P)
Cefixime
Cefpodoxime
Cefprozil
Ceftibuten
Cephoperazone
Cefsulodin
Ceftazidime
Cefepime
Cefpirome
Cephalosporin Classification
•First generation:
–Group 1: cephalosporins for parenteral administration with
moderate antibacterial activity and resistance to
Staphylococci b-lactamases; hydrolyzed by a large number
of Enterobacterial b-lactamases.
–Group 2: cephalosporins for oral administration with
moderate antibacterial activity and resistance to
Staphylococci b-lactamases; moderately resistant to some
Enterobacterial b-lactamases.
•Second generation:
–Group 3: cephalosporins for parenteral administration with
moderate antibacterial activity and resistant to most b-
lactamases.
Cephalosporin Classification
•Third generation:
–Group 4: cephalosporins for parenteral
administration with increased antibacterial activity
and resistant to most b-lactamases.
–Group 5: cephalosporins for oral administration
with increased antibacterial activity and resistant to
most b-lactamases.
–Group 6: cephalosporins for parenteral
administration active against Pseudomonas
aeruginosa and resistant to most b-lactamases.
Cephalosporin Classification
•Fourth generation:
–Group 7: cephalosporins for parenteral
administration with increased antibacterial activity
against Enterobacteria, moderate activity against
Pseudomonas aeruginosa, stable to hydrolysis by
most b-lactamases and with enhanced anti
staphylococcal activity.